Compile Data Set for Download or QSAR
Report error Found 80 of affinity data for UniProtKB/TrEMBL: Q9Y466
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655814(US20240067625, Compound 44)
Affinity DataEC50:  0.0120nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655823(US20240067625, Compound 56)
Affinity DataEC50:  0.0440nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655822(US20240067625, Compound 55)
Affinity DataEC50:  0.0410nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655821(US20240067625, Compound 53)
Affinity DataEC50:  0.00900nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655820(US20240067625, Compound 52)
Affinity DataEC50:  0.0260nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655819(US20240067625, Compound 51)
Affinity DataEC50:  0.0200nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655818(US20240067625, Compound 49)
Affinity DataEC50:  0.0330nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655817(US20240067625, Compound 48)
Affinity DataEC50:  0.0100nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655816(US20240067625, Compound 47)
Affinity DataEC50:  0.0130nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655815(US20240067625, Compound 45)
Affinity DataEC50:  0.0110nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655824(US20240067625, Compound 57)
Affinity DataEC50:  0.0750nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655813(US20240067625, Compound 43)
Affinity DataEC50:  6.91E+3nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655812(US20240067625, Compound 41)
Affinity DataEC50:  0.00600nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655811(US20240067625, Compound 40)
Affinity DataEC50:  0.0530nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655810(US20240067625, Compound 39)
Affinity DataEC50:  0.0280nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655809(US20240067625, Compound 37)
Affinity DataEC50:  0.0340nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655808(US20240067625, Compound 36)
Affinity DataEC50:  0.0130nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655807(US20240067625, Compound 35)
Affinity DataEC50:  0.0130nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655806(US20240067625, Compound 33)
Affinity DataEC50:  0.0190nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655805(US20240067625, Compound 32)
Affinity DataEC50:  0.0140nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655834(US20240067625, Compound 74)
Affinity DataEC50:  0.0100nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50553255(CHEBI:17898 | All-Trans-Retinal | Retinal)
Affinity DataEC50:  200nMAssay Description:Inverse agonist activity at TLX (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50178961(CHEMBL2385268)
Affinity DataEC50:  200nMAssay Description:Inverse agonist activity at TLX (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50409212(CHEMBL5277896)
Affinity DataEC50:  200nMAssay Description:Inverse agonist activity at TLX (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655840(US20240067625, Compound 96)
Affinity DataEC50:  0.00300nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655839(US20240067625, Compound 95)
Affinity DataEC50:  0.00300nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655838(US20240067625, Compound 94)
Affinity DataEC50:  0.00300nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655837(US20240067625, Compound 93)
Affinity DataEC50:  0.00400nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655836(US20240067625, Compound 76)
Affinity DataEC50:  0.0130nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655835(US20240067625, Compound 75)
Affinity DataEC50:  0.00800nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655804(US20240067625, Compound 31)
Affinity DataEC50:  0.0140nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655833(US20240067625, Compound 73)
Affinity DataEC50:  0.00800nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655832(US20240067625, Compound 72)
Affinity DataEC50:  0.00700nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655831(US20240067625, Compound 71)
Affinity DataEC50:  7.31E+3nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655830(US20240067625, Compound 70)
Affinity DataEC50:  0.00500nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655829(US20240067625, Compound 69)
Affinity DataEC50:  0.00800nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655828(US20240067625, Compound 64)
Affinity DataEC50:  0.00900nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655827(US20240067625, Compound 63)
Affinity DataEC50:  0.0120nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655826(US20240067625, Compound 62)
Affinity DataEC50:  0.0120nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM655825(US20240067625, Compound 61)
Affinity DataEC50:  0.0150nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50580569(CHEMBL5083628)
Affinity DataEC50:  5.20E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50584384(CHEMBL5090226 | US20240067625, Compound 30)
Affinity DataEC50:  1.00E+3nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50584383(CHEMBL5080162 | EN300-5601139)
Affinity DataEC50:  2.00E+4nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataKd:  500nMAssay Description:Binding affinity to TLX LBD expressed in His6-tagged Escherichia coli Rosetta assessed as binding constant measured after 300 sec at 200 mM by isothe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataEC50:  3.70E+4nMAssay Description:Agonist activity at TAE expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as renilla luciferase reporter activi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50580566(CHEMBL3304960)
Affinity DataEC50: >1.00E+5nMAssay Description:Agonist activity at TAE expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as renilla luciferase reporter activi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50404775(CHEMBL31888)
Affinity DataEC50:  4.30E+4nMAssay Description:Agonist activity at TAE expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as renilla luciferase reporter activi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50130262(2,3,4,9-Tetrahydro-1H-beta-carboline | CHEMBL26923...)
Affinity DataEC50: >1.00E+5nMAssay Description:Agonist activity at TAE expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as renilla luciferase reporter activi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataEC50:  3.20E+4nMAssay Description:Agonist activity at full length TLX activating element expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as dec...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Baylor College Of Medicine

US Patent
LigandPNGBDBM50061966(Isopropyl-[3-(naphthalen-1-yloxy)-propyl]-amine | ...)
Affinity DataEC50:  5.00E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
Displayed 1 to 50 (of 80 total ) | Next | Last >>
Jump to: